TRIM13 anticorps (N-Term)
Aperçu rapide pour TRIM13 anticorps (N-Term) (ABIN2387863)
Antigène
Voir toutes TRIM13 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 60-90, N-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- TRIM13, NT (TRIM13, LEU5, RFP2, RNF77, E3 ubiquitin-protein ligase TRIM13, B Cell chronic lymphocytic leukemia tumor suppressor Leu5, Leukemia-associated protein 5, Putative tumor suppressor RFP2, RING finger protein 77, Ret finger protein 2, Tripartite motif-containing protein 13)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- TRIM13 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 60-90 amino acids from the N-terminal region of human TRIM13.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- TRIM13 (Tripartite Motif Containing 13 (TRIM13))
-
Autre désignation
- TRIM13
-
NCBI Accession
- NP_005789, NP_434698, NP_001007279, NP_998755
-
UniProt
- O60858
Antigène
-